Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.6.1 (
sulfatase
)
3,205
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cystic fibrosis (CF) is associated with mutation and abnormal function of the
cystic fibrosis transmembrane conductance regulator
(
CFTR
) that affects cellular chloride transport. Clinically, CF of the lung is associated with excessive accumulation of secretions, including the sulfated glycosaminoglycans, chondroitin sulfate and dermatan sulfate (DS), both of which contain sulfated N-acetylgalactosamine residues. The
sulfatase
enzymes, which are a highly conserved group of enzymes with high specificity for designated sulfate groups, include
arylsulfatase B
, a lysosomal enzyme. Arylsulfatase B, also known as N-acetyl galactosamine 4-
sulfatase
, can degrade DS and chondroitin-4 sulfate. Previously reported data demonstrated diminished activity of
arylsulfatase B
in lymphoid cell lines of patients with CF compared to normal control subjects. Frequent infections with Pseudomonas, a
sulfatase
-producing organism, occur in patients with CF, whereas infections with Mycobacterium tuberculosis, which lacks
sulfatase
activity, are infrequent. Additional investigation to determine if diminished function of
arylsulfatase B
is a consistent finding in cells of patients with CF may be informative, and may help to correlate the molecular, biochemical, and clinical characteristics of CF.
...
PMID:Does deficiency of arylsulfatase B have a role in cystic fibrosis? 1279 51